With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.246047-72-3,(1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium,as a common compound, the synthetic route is as follows.
Complex 1 (2.0 grams) was dissolved in toluene (10 mL), and 3-bromopyridine (1.50 grams, 4 mol equivalents) was added. The reaction flask was purged with argon and the reaction mixture was stirred for approximately 12 hours at about 20 C. to about 25 C. during which time a color change from dark purple to light green was observed. The reaction mixture was transferred into 75 mL of cold (about 0 C.) pentane, and a light green solid precipitated. The precipitate was filtered, washed with 4¡Á20 mL of cold pentane, and dried under vacuum to afford (IMesH2)(C5H4BrN)2(Cl)2RuCHPh 6 as a light green powder (1.8 grams, 86% yield).
246047-72-3, As the paragraph descriping shows that 246047-72-3 is playing an increasingly important role.
Reference£º
Patent; California Institute of Technology; Cymetech, LLP; US6759537; (2004); B2;,
Highly efficient and robust molecular ruthenium catalysts for water oxidation
Catalysts | Special Issue : Ruthenium Catalysts – MDPI